This one-hour program will cover the latest developments in antitrust litigation, transactions, and enforcement from September 2016, and will be presented by attorneys from our Antitrust and Competition Practice.

Among the topics we will cover:

Non-Merger Antitrust Litigation: Several important new circuit court opinions that highlight the importance of proper market definition (e.g., the American Express, Time Warner, and Mylan Pharmaceuticals cases) and address issues of class certification (e.g., In re Modafinil and Wallach v. Eaton Corp.)

U.S. Merger Enforcement: The Third Circuit’s decision in FTC v. Penn State Hershey Medical Center; a noteworthy speech on DOJ merger enforcement policy by Acting Assistant Attorney General Renata Hesse; and an update on ongoing merger litigation.

Cartels & Criminal Practice: Significant recent developments in civil cartel cases including cases addressing the scope of the FTAIA; the Second Circuit’s decision in the Vitamin C litigation; and a recent DOJ prosecution for obstruction of justice.

Developments in the European Commission: In merger practice, the new German “size of transaction” threshold and upcoming consultation on revising the EU Merger Regulation; also, the increasing scrutiny in the EC of the role of data and the Judgment of the General Court in Lundbeck v European Commission

Intellectual Property & Antitrust: The FTC’s new study, Patent Assertion Entity Activity